Finland· FI-REL-REL2271

Calcii Gluconas

A calcium gluconate product containing calcium gluconate + calcium saccharin, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 3 of our 19 countries.

ATC A12AA03

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedCalcii GluconasATCA12AA03REGISTER NO.FI-REL-REL2271PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Calcium gluconate is registered in 3 of 19 countries.

Countries holding a registration under ATC A12AA03 (calcium gluconate), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 2 of them publish a price we can compare per daily dose

Calcium gluconate · ATC A12AA03

3 / 19 countries

  • Finlandprice
  • Japan
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Calcium gluconate + Calcium saccharin
Manufacturer
Orion Corporation Orion Pharma
Country
Finland (FI)
ATC code
A12AA03
ATC class
Calcium gluconate
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for calcium gluconate.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Calcium gluconate · interactions on record

82 records

  • 5 severe
  • 75 moderate

Most severe, free to view

  • DigitoxinC01AA04severe
  • DigoxinC01AA05severe
  • CeftriaxoneJ01DD04severe
  • DolutegravirJ05AJ03severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/178b36e6-8f7b-4740-9f4e-c64779a6e7af
GET /v1/drugs/178b36e6-8f7b-4740-9f4e-c64779a6e7af?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "3",
  "form": "injektioneste",
  "route": null,
  "ddd_unit": "g",
  "strength": "100 mg/ml",
  "atc_label": "kalsiumglukonaatti",
  "ma_number": "9676",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL2271",
  "authorised_at": "1988-06-01"
}

See everything about calcium gluconate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.